{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T20:29:18Z","timestamp":1776198558742,"version":"3.50.1"},"reference-count":65,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1097\/ypg.0b013e328335125d","type":"journal-article","created":{"date-parts":[[2009,12,21]],"date-time":"2009-12-21T15:40:55Z","timestamp":1261410055000},"page":"25-30","source":"Crossref","is-referenced-by-count":52,"title":["Fluoxetine response in impulsive\u2013aggressive behavior and serotonin transporter polymorphism in personality disorder"],"prefix":"10.1097","volume":"20","author":[{"given":"Hern\u00e1n","family":"Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Iturra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldo","family":"Solari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juana","family":"Villarroel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Jerez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe","family":"Galleguillos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Leonor","family":"Bustamante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"10","key":"R1-5-20210213","first-page":"1","article-title":"Practice guidelines for the treatment of patients with borderline personality disorder","volume":"158","year":"2001","journal-title":"Am J Psychiatry"},{"key":"R2-5-20210213","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/01.jcp.0000095350.32154.73","article-title":"5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow up study","volume":"23","author":"Arias","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"R3-5-20210213","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0006-3223(00)00891-X","article-title":"Possible association between serotonin transporter gene polymorphism and violent suicidal behavior in mood disorders","volume":"48","author":"Bellivier","year":"2000","journal-title":"Biol Psychiatry"},{"key":"R4-5-20210213","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/sj.mp.4000678","article-title":"Possible association of the short allele of the serotonin transporter promoter gene polymorphism (5-HTTLPR) with violent suicide","volume":"5","author":"Bondy","year":"2000","journal-title":"Mol Psychiatry"},{"key":"R5-5-20210213","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0006-3223(00)01018-0","article-title":"Absence of 5-HT1B receptors is associated with impaired impulse control in male 5-HT1B knockout mice","volume":"49","author":"Bouwknecht","year":"2001","journal-title":"Biol Psychiatry"},{"key":"R6-5-20210213","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0165-1781(79)90053-2","article-title":"Aggression in humans correlates with cerebrospinal fluid amine metabolites","volume":"1","author":"Brown","year":"1979","journal-title":"Psychiatry Res"},{"key":"R7-5-20210213","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1176\/ajp.139.6.741","article-title":"Aggression, suicide, and serotonin: relationships to CSF amine metabolites","volume":"139","author":"Brown","year":"1982","journal-title":"Am J Psychiatry"},{"key":"R8-5-20210213","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S1134-5934(06)75356-8","article-title":"Identificaci\u00f3n de una variante gen\u00e9tica de triptofano hidroxilasa 2 en poblaci\u00f3n chilena (Identification of a tryptophan hydroxylase 2 variant in Chilean population)","volume":"13","author":"Bustamante","year":"2006","journal-title":"Psiquiatr\u00eda Biol\u00f3gica"},{"key":"R9-5-20210213","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psychres.2006.03.013","article-title":"Relations of serotonin function to personality: current views and a key methodological issue","volume":"144","author":"Carver","year":"2006","journal-title":"Psychiatry Res"},{"issue":"Suppl","key":"R10-5-20210213","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1192\/S0007125000291769","article-title":"Central serotonin and impulsive aggression","volume":"139","author":"Coccaro","year":"1989","journal-title":"Br J Psychiatry"},{"key":"R11-5-20210213","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/archpsyc.1997.01830240035005","article-title":"Fluoxetine and impulsive aggressive behavior in personality-disordered participants","volume":"54","author":"Coccaro","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"R12-5-20210213","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1001\/archpsyc.1989.01810070013002","article-title":"Serotonergic studies in affective and personality disorders patients: correlates with suicidal and impulsive aggressive behavior","volume":"46","author":"Coccaro","year":"1989","journal-title":"Arch Gen Psychiatry"},{"key":"R13-5-20210213","first-page":"373","article-title":"Fluoxetine treatment on impulsive aggression in DSM-III-R personality disorder patients","volume":"10","author":"Coccaro","year":"1990","journal-title":"J Clin Psychiatry"},{"key":"R14-5-20210213","first-page":"S44","article-title":"Development of neuropharmacologically based behavioral assessment of impulsive aggressive behavior","volume":"3","author":"Coccaro","year":"1991","journal-title":"Clin Neurosci"},{"key":"R15-5-20210213","first-page":"116","article-title":"A preliminary trial of fluoxetine in refractory borderline patients","volume":"11","author":"Cornelius","year":"1991","journal-title":"J Clin Psychiatry"},{"key":"R16-5-20210213","first-page":"151","article-title":"Fluoxetine trial in borderline personality disorder","volume":"26","author":"Cornelius","year":"1990","journal-title":"Psychopharmacol Bull"},{"key":"R17-5-20210213","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.biopsych.2003.07.004","article-title":"Serotonin transporter gene may be involved in short-term risk of subsequent suicide attempts","volume":"55","author":"Courtet","year":"2004","journal-title":"Biol Psychiatry"},{"key":"R18-5-20210213","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/sj.mp.4000689","article-title":"Serotonin transporter linked polymorphic region in anorexia nervosa and bulimia nervosa","volume":"5","author":"Di Bella","year":"2000","journal-title":"Mol Psychiatry"},{"key":"R19-5-20210213","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1017\/S0033291799002822","article-title":"Impulsiveness, serotonin genes and repetition of deliberate self-harm (DSH)","volume":"30","author":"Evans","year":"2000","journal-title":"Psychol Med"},{"key":"R20-5-20210213","article-title":"Structured Clinical Interview for DSM-IV Axis I Disorders\u2014Patient Edition (SCID-I\/P), Version 2.0","author":"First","year":"1995"},{"key":"R21-5-20210213","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s004390050624","article-title":"Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria in African and European--American and Japanese populations and in alcohol-dependent subjects","volume":"101","author":"Gelernter","year":"1997","journal-title":"Hum Genet"},{"key":"R22-5-20210213","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2165\/00129785-200404010-00002","article-title":"Eating disorders, serotonin transporter polymorphisms and potential treatment response","volume":"4","author":"Gorwood","year":"2004","journal-title":"Am J Pharmacogenomics"},{"key":"R23-5-20210213","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1046\/j.1471-4159.1996.66062621.x","article-title":"Allelic variation of human serotonin transporter gene expression","volume":"66","author":"Heils","year":"1996","journal-title":"J Neurochem"},{"key":"R24-5-20210213","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1086\/503850","article-title":"Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder","volume":"78","author":"Hu","year":"2006","journal-title":"Am J Hum Genet"},{"key":"R25-5-20210213","first-page":"137","article-title":"An open trial of sertraline in personality disordered patients with impulsive aggression","volume":"5","author":"Kavoussi","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"R26-5-20210213","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00001756-200001170-00042","article-title":"Serotonin transporter gene polymorphism and antidepressant response","volume":"11","author":"Kim","year":"2000","journal-title":"Neuroreport"},{"issue":"3","key":"R27-5-20210213","first-page":"S235","article-title":"Individualized medicine-implementation of pharmacogenetic diagnostics in antidepressant drug treatment of major depressive disorders","volume":"36","author":"Kircheiner","year":"2003","journal-title":"Pharmacopsychiatry"},{"key":"R28-5-20210213","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.biopsych.2006.07.017","article-title":"Analysis of association between the serotonin transporter and antidepressant response in a large clinical sample","volume":"61","author":"Kraft","year":"2007","journal-title":"Biol Psychiatry"},{"key":"R29-5-20210213","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1006\/geno.1995.1042","article-title":"Identification, expression, and pharmacology of a Cys23-Ser23 substitution in the human 5-HT2c receptor gene (HTR2C)","volume":"27","author":"Lappalainen","year":"1995","journal-title":"Genomics"},{"key":"R30-5-20210213","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/archpsyc.55.11.989","article-title":"Linkage of antisocial alcoholism to the serotonin 5-HT1B receptor gene in two populations","volume":"55","author":"Lappalainen","year":"1998","journal-title":"Arch Gen Psychiatry"},{"key":"R31-5-20210213","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0165-1781(03)00065-9","article-title":"Possible association between serotonin transporter promoter region polymorphism and impulsivity in Koreans","volume":"118","author":"Lee","year":"2003","journal-title":"Psychiatry Res"},{"key":"R32-5-20210213","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.pnpbp.2005.03.012","article-title":"Pharmacogenetics of the serotonin transporter","volume":"29","author":"Lesch","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R33-5-20210213","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1126\/science.274.5292.1527","article-title":"Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region","volume":"246","author":"Lesch","year":"1996","journal-title":"Science"},{"key":"R34-5-20210213","article-title":"International personality disorders examination (IPDE): DSM-IV module","author":"Loranger","year":"1999"},{"key":"R35-5-20210213","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1176\/ajp.148.8.1064","article-title":"Fluoxetine in the treatment on borderline and schizotypal personality disorders","volume":"148","author":"Markovitz","year":"1991","journal-title":"Am J Psychiatry"},{"key":"R36-5-20210213","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/sj.mp.4001683","article-title":"Serotonin transporter polymorphism and potential response to SSRIs in bulimia nervosa","volume":"10","author":"Monteleone","year":"2005","journal-title":"Mol Psychiatry"},{"key":"R37-5-20210213","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ajmg.b.30232","article-title":"Association of a functional serotonin transporter gene polymorphism with binge eating disorder","volume":"141","author":"Monteleone","year":"2006","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"R38-5-20210213","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/hup.608","article-title":"Differential effects of fluvoxamine, paroxetine and milnacipram for depression, especially with regard to age","volume":"19","author":"Morishita","year":"2004","journal-title":"Hum Psychopharmacol"},{"key":"R39-5-20210213","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/(SICI)1096-8628(19980207)81:1<13::AID-AJMG3>3.0.CO;2-O","article-title":"Tryptophan hydroxylase genotype is associated with impulsive-aggression measures: a preliminary study","volume":"81","author":"New","year":"1998","journal-title":"Am J Med Genet"},{"key":"R40-5-20210213","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00213-004-1913-8","article-title":"Fluoxetine increases relative metabolic rate in prefrontal cortex in impulsive aggression","volume":"176","author":"New","year":"2004","journal-title":"Psychopharmacol"},{"key":"R41-5-20210213","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archpsyc.55.7.593","article-title":"A tryptophan hydroxylase gene marker for suicidality and alcoholism","volume":"55","author":"Nielsen","year":"1998","journal-title":"Arch Gen Psychiatry"},{"key":"R42-5-20210213","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/0278-5846(89)90040-7","article-title":"Fluoxetine in borderline personality disorder","volume":"13","author":"Norden","year":"1989","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R43-5-20210213","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1192\/bjp.160.5.643","article-title":"Blunted prolactin responses to D-fenfluramine in sociopathy: evidence for subsensitivity of central serotonergic function","volume":"160","author":"O'Keane","year":"1992","journal-title":"Br J Psychiatry"},{"key":"R44-5-20210213","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0193-953X(05)70140-4","article-title":"The biology of impulsivity and suicidality","volume":"23","author":"Oquendo","year":"2000","journal-title":"Psychiatr Clin North Am"},{"key":"R45-5-20210213","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/sj.mp.4001502","article-title":"Investigation of serotonin-related genes in antidepressant response","volume":"9","author":"Peters","year":"2004","journal-title":"Mol Psychiatry"},{"key":"R46-5-20210213","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.pnpbp.2005.03.011","article-title":"Initial conditions of psychotropic drug response: Studies of serotonin transporter long promoter region (5-HTTLPR), serotonin transporter efficiency, cytokine and kinase gene expression relevant to depression and antidepressant outcome","volume":"29","author":"Rausch","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R47-5-20210213","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1176\/appi.ajp.159.12.2048","article-title":"SSRI treatment of borderline personality disorder: a randomized, placebo-controlled clinical trial for female patients with borderline personality patients","volume":"159","author":"Rinne","year":"2002","journal-title":"Am J Psychiatry"},{"key":"R48-5-20210213","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/sj.mp.4000578","article-title":"Identification of four variants in the tryptophan hydroxylase promoter and association to behavior","volume":"4","author":"Rotondo","year":"1999","journal-title":"Mol Psychiatry"},{"key":"R49-5-20210213","first-page":"23","article-title":"Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder","volume":"15","author":"Salzman","year":"1995","journal-title":"J Clin Psychiatry"},{"key":"R50-5-20210213","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s00213-004-1822-x","article-title":"From molecular biology to pharmacogenetics: a review of the literature on antidepressant treatment and suggestions of possible candidate genes","volume":"174","author":"Serretti","year":"2004","journal-title":"Psychopharmacol"},{"key":"R51-5-20210213","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/sj.mp.4000876","article-title":"Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity","volume":"6","author":"Serretti","year":"2001","journal-title":"Mol Psychiatry"},{"key":"R52-5-20210213","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0014-2999(02)01309-2","article-title":"Pharmacogenetics in affective disorders","volume":"438","author":"Serretti","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"R53-5-20210213","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.pnpbp.2005.03.013","article-title":"The influence of serotonin transporter promoter polymorphism (SERTPR) and other polymorphisms of the serotonin pathway on the efficacy of antidepressant treatments","volume":"29","author":"Serretti","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R54-5-20210213","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.psychres.2005.09.020","article-title":"Pooling pharmacogenetic studies on the serotonin transporter: a mega-analysis","volume":"145","author":"Serretti","year":"2006","journal-title":"Psychiatry Res"},{"key":"R55-5-20210213","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/sj.mp.4001926","article-title":"Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients","volume":"12","author":"Serretti","year":"2007","journal-title":"Mol Psychiatry"},{"key":"R56-5-20210213","first-page":"387","article-title":"Serotonin transporter polymorphism and fluoxetine effect on impulsiveness and aggression in borderline personality disorder","volume":"35","author":"Silva","year":"2007","journal-title":"Actas Esp Psiquiatr"},{"key":"R57-5-20210213","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/sj.mp.4000425","article-title":"Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine","volume":"3","author":"Smeraldi","year":"1998","journal-title":"Mol Psychiatry"},{"key":"R58-5-20210213","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0193-953X(05)70150-7","article-title":"Psychopharmacology of borderline personality disorder","volume":"23","author":"Soloff","year":"2000","journal-title":"Psychiatr Clin North Am"},{"key":"R59-5-20210213","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/ajmg.10405","article-title":"A dimensional impulsive-aggressive phenotype is associated with the A218C polymorphism of the tryptophan hydroxylase gene: a pilot study in well-characterized impulsive inpatients","volume":"114","author":"Staner","year":"2002","journal-title":"Am J Med Genet"},{"key":"R60-5-20210213","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s00213-006-0349-8","article-title":"Serotonin transporter gene promoter polymorphism predicts SSRI response in generalized social anxiety disorder","volume":"187","author":"Stein","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"R61-5-20210213","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1093\/clinchem\/38.9.1756","article-title":"A sensitive and selective liquid chromatographic method using fluorescence detection for plasma fluoxetine and nor-fluoxetine","volume":"38","author":"Suckow","year":"1992","journal-title":"Clin Chem"},{"key":"R62-5-20210213","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/sj.mp.4000816","article-title":"TPH and suicidal behavior: a study in suicide completers","volume":"6","author":"Turecki","year":"2001","journal-title":"Mol Psychiatry"},{"key":"R63-5-20210213","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1126\/science.1078197","article-title":"Synthesis of serotonin by a second tryptophan hydroxylase isoform","volume":"299","author":"Walther","year":"2003","journal-title":"Science"},{"key":"R64-5-20210213","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0278-5846(01)00287-1","article-title":"Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients","volume":"26","author":"Yoshida","year":"2002","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R65-5-20210213","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuron.2004.12.014","article-title":"Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression","volume":"45","author":"Zhang","year":"2005","journal-title":"Neuron"}],"container-title":["Psychiatric Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00041444-201002000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T01:28:14Z","timestamp":1618277294000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00041444-201002000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/ypg.0b013e328335125d","relation":{},"ISSN":["0955-8829"],"issn-type":[{"value":"0955-8829","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}